NasdaqCM:LFVN

Stock Analysis Report

Executive Summary

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and personal care products.

Snowflake

Fundamentals

Flawless balance sheet with proven track record.


Similar Companies

Share Price & News

How has LifeVantage's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

3.2%

LFVN

-0.6%

US Personal Products

0.07%

US Market


1 Year Return

39.3%

LFVN

26.3%

US Personal Products

8.9%

US Market

Return vs Industry: LFVN exceeded the US Personal Products industry which returned 26.3% over the past year.

Return vs Market: LFVN exceeded the US Market which returned 8.9% over the past year.


Shareholder returns

LFVNIndustryMarket
7 Day3.2%-0.6%0.07%
30 Day5.5%-1.2%-0.3%
90 Day32.7%-0.7%-1.6%
1 Year39.3%39.3%28.3%26.3%11.3%8.9%
3 Year70.5%70.5%43.3%36.0%46.3%36.8%
5 Year59.5%59.5%79.9%61.8%62.1%44.3%

Price Volatility Vs. Market

How volatile is LifeVantage's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is LifeVantage undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: LFVN ($14.85) is trading below our estimate of fair value ($38.69)

Significantly Below Fair Value: LFVN is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: LFVN is poor value based on its PE Ratio (28.1x) compared to the Personal Products industry average (17.5x).

PE vs Market: LFVN is poor value based on its PE Ratio (28.1x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate LFVN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LFVN is overvalued based on its PB Ratio (7.7x) compared to the US Personal Products industry average (3.2x).


Next Steps

Future Growth

How is LifeVantage forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

5.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: LFVN's forecast earnings growth (5.1% per year) is above the savings rate (2.7%).

Earnings vs Market: LFVN's earnings (5.1% per year) are forecast to grow slower than the US market (14.5% per year).

High Growth Earnings: LFVN's earnings are forecast to grow, but not significantly.

Revenue vs Market: Insufficient data to determine if LFVN's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if LFVN's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if LFVN's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has LifeVantage performed over the past 5 years?

-17.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: LFVN's earnings have declined by -17.4% per year over the past 5 years.

Accelerating Growth: LFVN's earnings growth over the past year (29%) exceeds its 5-year average (-17.4% per year).

Earnings vs Industry: LFVN earnings growth over the past year (29%) exceeded the Personal Products industry 25.2%.


Return on Equity

High ROE: LFVN's Return on Equity (27.3%) is considered high.


Return on Assets

ROA vs Industry: LFVN has a higher Return on Assets than the Personal Products industry average last year.


Return on Capital Employed

ROCE Improving: LFVN's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is LifeVantage's financial position?


Financial Position Analysis

Short Term Liabilities: LFVN's short term assets ($43.2M) exceeds its short term liabilities ($26.2M)

Long Term Liabilities: LFVN's short term assets (43.2M) exceeds its long term liabilities (1.9M)


Debt to Equity History and Analysis

Debt Level: LFVN's debt to equity ratio (5.3%) is considered satisfactory

Reducing Debt: LFVN's debt to equity ratio has reduced from 739.4% to 5.3% over the past 5 years.

Debt Coverage: LFVN's debt is well covered by operating cash flow (1223.5%).

Interest Coverage: LFVN's interest payments on its debt are well covered by EBIT (30.4x coverage).


Balance Sheet

Inventory Level: LFVN has a high level of physical assets or inventory.

Debt Coverage by Assets: LFVN's debt is covered by short term assets (assets are 29.7x debt).


Next Steps

Dividend

What is LifeVantage's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.5%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate LFVN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate LFVN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if LFVN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LFVN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LFVN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of LifeVantage's salary, the management and board of directors tenure and is there insider trading?

3.6yrs

Average management tenure


CEO

Darren Jensen (50yo)

4.4yrs

Tenure

US$5,025,497

Compensation

Mr. Darren Jay Jensen has been the Chief Executive Officer and President of Lifevantage Corp. since May 18, 2015 and has been its Director since January 8, 2016. From June 2014 to May 2015, Mr. Jensen serv ...


CEO Compensation Analysis

Compensation vs. Market: Darren's total compensation ($USD5.03M) is about average for companies of similar size in the US market ($USD1.22M).

Compensation vs Earnings: Darren's compensation has increased by more than 20% in the past year.


Management Age and Tenure

3.6yrs

Average Tenure

51yo

Average Age

Experienced Management: LFVN's management team is considered experienced (3.6 years average tenure).


Board Age and Tenure

2.7yrs

Average Tenure

59yo

Average Age

Experienced Board: LFVN's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$19,83030 Nov 18
Raymond Greer
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares1,500
Max PriceUS$13.22
BuyUS$13,73127 Nov 18
Garry Mauro
EntityIndividual
Role
Chairman of the Board
Independent Chairman
Shares1,150
Max PriceUS$11.94

Ownership Breakdown


Management Team

  • Eric Marchant

    Vice President of Compliance

    • Tenure: 0yrs
  • Steven Fife (58yo)

    Chief Financial Officer

    • Tenure: 2.6yrs
    • Compensation: US$1.55m
  • Darren Jensen (50yo)

    President

    • Tenure: 4.4yrs
    • Compensation: US$5.03m
  • Justin Rose (51yo)

    Chief Sales Officer

    • Tenure: 4.3yrs
    • Compensation: US$1.13m
  • Michelle Oborn-Virchow (39yo)

    Senior Vice President of Human Resources

    • Tenure: 3.9yrs
    • Compensation: US$627.21k
  • Kevin McMurray (57yo)

    General Counsel

    • Tenure: 2.1yrs
    • Compensation: US$1.04m
  • Ryan Goodwin (42yo)

    Chief Marketing Officer

    • Tenure: 4yrs
    • Compensation: US$1.11m
  • Dave Fleming

    Senior Vice President of Global Field Development - Americas & Europe

    • Tenure: 3.3yrs
  • Chuck Wach (57yo)

    Chief Operating Officer

    • Tenure: 2.6yrs
    • Compensation: US$572.31k
  • Chris Taylor

    Director of Communications

    • Tenure: 0yrs

Board Members

  • Michael Beindorff (67yo)

    Independent Director

    • Tenure: 7.8yrs
    • Compensation: US$217.59k
  • Ray Greer (56yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$211.59k
  • Darwin Lewis (60yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$217.59k
  • Garry Mauro (71yo)

    Independent Chairman

    • Tenure: 5.9yrs
    • Compensation: US$223.59k
  • Darren Jensen (50yo)

    President

    • Tenure: 4.4yrs
    • Compensation: US$5.03m
  • Vinayak Hegde (49yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$211.59k
  • Erin Brockovich (59yo)

    Independent Director

    • Tenure: 0.4yrs
    • Compensation: US$50.94k

Company Information

LifeVantage Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: LifeVantage Corporation
  • Ticker: LFVN
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$208.405m
  • Shares outstanding: 14.03m
  • Website: https://www.lifevantage.com

Number of Employees


Location

  • LifeVantage Corporation
  • 9785 South Monroe Street
  • Suite 400
  • Sandy
  • Utah
  • 84070
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LFVNNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDOct 2004
L2T1DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2004

Biography

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and personal care products. The company offers Protandim, a line of scien ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/23 23:52
End of Day Share Price2019/10/23 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.